Labcorp (LH)

• Market cap: $19.1B
• 1 day: 0.72%
• 5 days: -1.55%
• 1 month: -3.88%
• 3 months: 2.88%
• 6 months: 10.24%
• Year to date: -1.70%
• 1 year: 3.82%
• 5 years: 36.24%
• 10 years: 113.38%
• Sector: Healthcare
• Industry: Medical Laboratories

About: Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Employees: 67,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

84% more first-time investments, than exits

New positions opened: 136 | Existing positions closed: 74

7% more funds holding

Funds holding: 840 [Q2] → 902 (+62) [Q3]

4% more capital invested

Capital invested by funds: $16.1B [Q2] → $16.8B (+$677M) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 308 | Existing positions reduced: 307

4.29% less ownership

Funds ownership: 93.95% [Q2] → 89.66% (-4.29%) [Q3]

13% less funds holding in top 10

Funds holding in top 10: 8 [Q2] → 7 (-1) [Q3]

22% less call options, than puts

Call options by funds: $41.3M | Put options by funds: $52.9M

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $240 5% upside
• Avg. target: $262 15% upside
• High target: $289 26% upside

7 analyst ratings

• positive: 4 57%
• neutral: 3 43%
• negative: 0 0%

Morgan Stanley Ricky Goldwasser 44% 1-year accuracy 7 / 16 met price target	18% upside $270	Overweight Maintained	17 Dec 2024
B of A Securities Derik De Bruin 32% 1-year accuracy 6 / 19 met price target	19% upside $271	Buy Maintained	13 Dec 2024
Jefferies Brian Tanquilut 54% 1-year accuracy 7 / 13 met price target	20% upside $275	Buy Assumed	10 Dec 2024
Piper Sandler David Westenberg 69% 1-year accuracy 27 / 39 met price target	5% upside $240	Neutral Maintained	28 Oct 2024
Barclays Jack Meehan 50% 1-year accuracy 1 / 2 met price target	9% upside $249	Equal-Weight Maintained	25 Oct 2024